Pfizer Plans Exubera “Full Court Press”’ In 2007 After 2006 Stumbles

Pfizer is finally ramping up for a full-scale launch of the inhaled insulin Exubera - targeting primary care physicians and consumers - over one year after the drug was approved by FDA